Skip to content

Clinical research plan of real world cohort study on the whole course of treatment of mycoplasma pneumoniae pneumonia in children based on the experience of Chinese medicine masters

Construction of clinical research and efficacy evaluation system based on the experience of Chinese medicine masters in the treatment of mycoplasma pneumoniae pneumonia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001650
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae pneumonia

Interventions

exposure group:( 1 ) Chinese medicine treatment plan Wind-heat closed lung syndrome : Sangju Zhisou Granule usage : 1-3 years old, 1.5 bags each time, daily 2 times, water wash clothes
4-6 years old, 2 bags each time, 2 times a day, washed with water
over 7 years old, each time 3 bags, 2 times a day, washed with water. Course of treatment : 14 days. Phlegm heat closed lung syndrome : Maxing Qingdi Decoction granule usage : 1-3 years old, 1.5 bags
over 7 years old. 3 bags each time, 2 times a day, washed with water. Course of treatment : 14 days. Yin deficiency and lung heat syndrome : Shamai Yifei granule usage : 1-3 years old, 1.5 bags each
over 7 years old, 3 bags each time, 2 times a day, washed with water. Course of treatment : 14 days. This study will truthfully record the usage and dosage and course of treatment according to the doc

Sponsors

the First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1 Age 1-16 years old, male or female ; 2 Patients who met the diagnostic criteria of Mycoplasma pneumoniae pneumonia in Western medicine and hospitalized children with TCM syndrome differentiation criteria ; 3 children with normal blood routine, total white blood cell count of ( 4.0-12.0 ) × 109 / L, neutrophil ratio of 50 % -75 %, or patients who were judged by researchers not to need antimicrobial therapy ; 4 The guardians of the selected children voluntarily signed the informed consent form, and the children aged = 8 years old needed to voluntarily sign the informed consent form. No serious heart, brain, kidney damage and circulatory, nervous system damage.

Exclusion criteria

Exclusion criteria: 1 The researchers determined that the patients with bacterial and viral infections had white blood cells = 13 × 109 / L, mainly neutrophils or positive respiratory virus nucleic acid test. 2 patients who were known to be allergic to the therapeutic drugs in the research program ; children with continuous use of azithromycin, erythromycin, minocycline, doxycycline, levofloxacin, moxifloxacin and other macrolides or ketolactones, prednisone, methylprednisolone and other glucocorticoid drugs, gamma globulin ( IVIG ) in the first 3 days before enrollment ; 3. 4 children with continuous use of Chinese patent medicines and decoction pieces with heat-clearing and detoxifying, cough-relieving and phlegm-expelling effects within 3 days before enrollment ; 5 life-threatening complications, such as empyema, pneumothorax, lung abscess, necrotizing pneumonia, acute respiratory failure and other serious intrapulmonary complications, or septic shock, viral encephalopathy, and persistent lesions and other serious extrapulmonary complications ; 6 diseases that need to be identified with MPP, such as pulmonary tuberculosis and other uncommon fungal pathogens such as microbial pneumonia ; 7.Pulmonary infection secondary to primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformation, pulmonary dysplasia, aspiration pneumonia, pulmonary malignant tumor and other basic diseases ; 8 poor compliance, unable to cooperate with treatment, follow-up or fill in the study records of children.

Design outcomes

Primary

MeasureTime frame
Disease efficacy;Number of days of complete cooling;3-day fever reduction rate;7-day fever reduction rate;lung image;Main symptoms curative effect;traditional chinese medicine syndrome;Symptom recurrence rate;etiology detection;laboratory index;serological indicators;

Countries

China

Contacts

Public ContactYAN Yongbin

the First Affiliated Hospital of Henan University of Traditional Chinese Medicine

yanyongbin827@sina.com155 1573 0918

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026